Descripción de la empresa
Brighthouse Financial, Inc. operates as a provider of annuity and life insurance products within the United States market, serving contract holders through its distinct Annuities, Life, and Run-off segments. The company functions within the Financial Services sector, specifically categorized under the Insurance - Life industry, which denotes a business model focused on long-term risk management and wealth preservation. The organization employs approximately 1,400 individuals to support its operations, while its total market capitalization and annual revenue figures are currently not disclosed in the available data. Although the specific market cap is unavailable, the reported annual revenue of $6.95 billion and the substantial cash reserves of $7.39 billion indicate a significant operational scale typical of major players in the insurance life sector. The revenue magnitude suggests a robust capacity to generate premiums, while the high cash holding relative to typical operational needs points to a balance sheet structure that may prioritize liquidity or strategic capital allocation over aggressive expansion in the current period.
Salud financiera
The company reported a total revenue of $6.95 billion for the trailing twelve months, with a net income of $331.00 million, while the EBITDA figure is not available for this reporting period. The substantial disparity between the $6.95 billion in revenue and the $331.00 million in net income highlights a cost structure where operating expenses and claims payouts consume the majority of gross premiums, resulting in a profit margin of 6.2%. This gap reveals that for every dollar of revenue generated, the company retains only 6.2 cents as profit after all costs, including the significant operational overhead required to underwrite life insurance contracts. Free cash flow stands at -$607,374,976, indicating that the company is currently spending more on capital expenditures or working capital changes than it generates from its core operations, which impacts short-term financial flexibility and the ability to fund internal growth without external financing. The gross margin is 33.8%, reflecting the cost of goods sold relative to revenue, while the operating margin of 21.3% demonstrates the efficiency of the core business before interest and taxes. The profit margin of 6.2% confirms that the bottom line is heavily influenced by non-operating factors or significant expense recognition. In terms of leverage, total cash stands at $7.39 billion against total debt of $9.94 billion, creating a net debt position, and the debt-to-equity ratio is recorded at 145.50, suggesting a highly leveraged balance sheet structure common in insurance firms but requiring careful monitoring. The current ratio is 0.68, which indicates that current assets are insufficient to cover current liabilities without relying on external funding or asset sales, signaling potential short-term liquidity constraints. Return on Equity is 7.4%, showing the return generated on shareholders' capital, whereas Return on Assets is only 0.2%, revealing that the large asset base typical of insurance companies yields very low returns on the total assets employed.
Evaluación de valoración
The trailing P/E ratio is 1.34, while the forward P/E ratio is not available, a situation that implies an inability to value future earnings expectations based on analyst projections or that forward earnings are not yet quantifiable in the current reporting cycle. The price-to-book ratio stands at 0.14, which indicates that the market values the company at only 14% of its book value, suggesting a deep discount relative to the tangible assets held on the balance sheet. Both the price-to-sales ratio and the EV/EBITDA ratio are not available in the current dataset, preventing a comparative analysis against traditional valuation multiples that often rely on sales consistency or enterprise value metrics. The 52-week high is $21.94 and the 52-week low is $14.19, and without a specific current stock price provided in the source data, the exact percentage deviation from the trading range cannot be calculated, though the range spans a total of $7.75. The beta is 0.92, which implies that the stock's price volatility is roughly 8% lower than the broader market, indicating a slightly less sensitive price movement to market-wide fluctuations compared to the average equity.
Growth & Income
Revenue growth year-over-year is -31.6%, and earnings growth year-over-year is -82.1%, demonstrating that earnings are contracting at a significantly faster rate than revenue, which is a rare dynamic often seen during restructuring or when one-time charges impact the bottom line more severely than the top line. The dividend yield is 10.0%, representing a very high return on capital for income-focused investors, although the payout ratio is not available to assess the sustainability of these distributions against the declining earnings. Given the negative earnings growth of -82.1% and the absence of a reported payout ratio, the high yield must be scrutinized carefully as it may be supported by retained earnings or asset values rather than current cash flow generation. The overall growth and income profile presents a complex picture of a company offering substantial income potential through a high dividend yield, yet facing significant headwinds in revenue and earnings contraction that challenge long-term growth sustainability.